Received Apr 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y006771 | — |
no adverse event; Physician reported an AE for PROQUAD. The caller said a dose was reconstituted with normal saline and administered to a patient on 3/20/2025. Confirmed with caller no other AE occurred. Caller provided consent for follow up. No other AE. No PQC.; This spontaneous report was received from a physician and refers to a 4-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 20-MAR-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y006771, expiration date: 24-Sep-2025) (1 dose), for prophylaxis. The reporter stated that a dose was reconstituted with normal saline (lot #HN2235, expiration date: 01-Oct-2025) and administered to the patient (product preparation error). The physician confirmed that no other adverse event occurred (no adverse event).
Normal saline